Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

AZRX

AzurRx BioPharma (AZRX)

AzurRx BioPharma Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AZRX
일자시간출처헤드라인심볼기업
2023/06/2806:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:AZRXAzurRx BioPharma Inc
2023/06/2405:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZRXAzurRx BioPharma Inc
2023/06/2105:26Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AZRXAzurRx BioPharma Inc
2023/06/1705:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZRXAzurRx BioPharma Inc
2023/06/0520:01Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:AZRXAzurRx BioPharma Inc
2023/05/1606:21Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:AZRXAzurRx BioPharma Inc
2023/05/1221:33Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AZRXAzurRx BioPharma Inc
2023/04/2205:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZRXAzurRx BioPharma Inc
2023/04/0805:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZRXAzurRx BioPharma Inc
2023/04/0605:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZRXAzurRx BioPharma Inc
2023/04/0605:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZRXAzurRx BioPharma Inc
2023/04/0506:29Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AZRXAzurRx BioPharma Inc
2023/04/0506:27Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AZRXAzurRx BioPharma Inc
2023/03/2819:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AZRXAzurRx BioPharma Inc
2023/03/2805:32Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:AZRXAzurRx BioPharma Inc
2023/03/2406:00Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:AZRXAzurRx BioPharma Inc
2023/03/2205:38Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:AZRXAzurRx BioPharma Inc
2023/03/2105:11Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AZRXAzurRx BioPharma Inc
2023/03/1600:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZRXAzurRx BioPharma Inc
2023/02/0721:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZRXAzurRx BioPharma Inc
2023/01/1723:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZRXAzurRx BioPharma Inc
2023/01/0923:23Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AZRXAzurRx BioPharma Inc
2023/01/0523:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZRXAzurRx BioPharma Inc
2023/01/0523:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZRXAzurRx BioPharma Inc
2023/01/0522:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZRXAzurRx BioPharma Inc
2023/01/0522:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZRXAzurRx BioPharma Inc
2022/12/2107:18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZRXAzurRx BioPharma Inc
2022/12/1706:34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZRXAzurRx BioPharma Inc
2022/12/0920:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AZRXAzurRx BioPharma Inc
2022/12/0806:17Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:AZRXAzurRx BioPharma Inc
 검색 관련기사 보기:NASDAQ:AZRX